Athersys drug discovery deal with Molecumetics

Athersys will use Random Activation of Gene Expression for Validated Targets (RAGE-VT) technology to provide Molecumetics, a chemistry-based drug discovery subsidiary of Tredegar (TG), with 12 cell li...